Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$5.08B |
| 2 |
Schwab Municipal Bond ETF
SCMB
|
+$1.29B |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$752M |
| 4 |
Microsoft
MSFT
|
+$699M |
| 5 |
NVIDIA
NVDA
|
+$578M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$4.9B |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$986M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$951M |
| 4 |
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
|
+$794M |
| 5 |
Schwab Fundamental International Small Company Index ETF
FNDC
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 9.33% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Applied Optoelectronics
AAOI
$11.7B
| $4.21M | ﹤0.01% |
163,836
+39,404
| +32% | +$638K |
|
2402
Hyster-Yale Materials Handling
HY
$614M
| $4.18M | ﹤0.01% |
105,070
+1,742
| +2% | +$69.4K |
|
|
SAGE
2403
DELISTED
Sage Therapeutics
SAGE
| $4.18M | ﹤0.01% |
458,248
+12,070
| +3% | +$88.8K |
|
2404
Hippo Holdings
HIPO
$868M
| $4.18M | ﹤0.01% |
149,555
-4,575
| -3% | -$113K |
|
|
LENZ
2405
LENZ Therapeutics
LENZ
$158M
| $4.17M | ﹤0.01% |
142,112
+18,066
| +15% | +$491K |
|
2406
Great Southern Bancorp
GSBC
$877M
| $4.16M | ﹤0.01% |
70,844
+693
| +1% | +$38.7K |
|
2407
GigaCloud Technology
GCT
$1.84B
| $4.16M | ﹤0.01% |
210,363
+168
| +0.1% | +$2.69K |
|
2408
Nuvation Bio
NUVB
$2.25B
| $4.16M | ﹤0.01% |
2,130,899
+226,758
| +12% | +$472K |
|
2409
Financial Institutions
FISI
$825M
| $4.15M | ﹤0.01% |
161,438
+1,100
| +0.7% | +$27.4K |
|
|
BFS
2410
Saul Centers
BFS
$850M
| $4.13M | ﹤0.01% |
121,094
+18,675
| +18% | +$630K |
|
2411
Ardagh Metal Packaging
AMBP
$3.02B
| $4.13M | ﹤0.01% |
964,197
+218,211
| +29% | +$791K |
|
2412
Clearfield
CLFD
$395M
| $4.1M | ﹤0.01% |
94,391
-1,434
| -1% | -$49.2K |
|
2413
ArriVent BioPharma
AVBP
$1.47B
| $4.1M | ﹤0.01% |
188,202
-8,292
| -4% | -$172K |
|
2414
Honda
HMC
$40.6B
| $4.08M | ﹤0.01% |
141,682
+13,879
| +11% | +$405K |
|
2415
uniQure
QURE
$3.13B
| $4.08M | ﹤0.01% |
292,931
+12,932
| +5% | +$174K |
|
2416
Ameresco
AMRC
$1.47B
| $4.04M | ﹤0.01% |
265,977
+37,755
| +17% | +$494K |
|
2417
Kura Oncology
KURA
$882M
| $4.03M | ﹤0.01% |
699,303
+76,163
| +12% | +$467K |
|
2418
TFS Financial
TFSL
$4.89B
| $4.03M | ﹤0.01% |
311,226
+1,851
| +0.6% | +$23.8K |
|
2419
Globant
GLOB
$1.67B
| $4.03M | ﹤0.01% |
44,344
+19,315
| +77% | +$2.06M |
|
2420
ARKO Corp
ARKO
$500M
| $4.02M | ﹤0.01% |
951,257
+203,148
| +27% | +$887K |
|
2421
iRadimed
IRMD
$1.12B
| $4.02M | ﹤0.01% |
67,286
+2,215
| +3% | +$121K |
|
2422
PACS Group
PACS
$7.2B
| $4.01M | ﹤0.01% |
310,033
-12,771
| -4% | -$133K |
|
2423
Root
ROOT
$748M
| $4M | ﹤0.01% |
31,223
+6,929
| +29% | +$939K |
|
2424
Playtika
PLTK
$904M
| $3.99M | ﹤0.01% |
844,268
+125,005
| +17% | +$615K |
|
2425
VanEck High Yield Muni ETF
HYD
$4.4B
| $3.97M | ﹤0.01% |
79,121
-1,345
| -2% | -$67.1K |
|
Similar funds
Charles Schwab's Q2 2025 Portfolio in Review
As of Q2 2025, Charles Schwab held 3,631 positions worth $578B, up 8.5% from $533B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab's Q2 2025 filing shows 158 new, 2,252 increased, 1,020 reduced and 137 closed positions. Its largest new stake was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B. The largest sale was Vanguard Mortgage-Backed Securities ETF, an estimated $4.9B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2025 buy was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B.
- Charles Schwab added most to Schwab Municipal Bond ETF in Q2 2025, an estimated $1.29B increase.
- Charles Schwab's biggest Q2 2025 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $4.9B.
- Charles Schwab fully exited Invesco FTSE RAFI US 1000 ETF in Q2 2025, selling an estimated $986M.
- Charles Schwab's ten largest holdings make up 23% of its $578B portfolio in Q2 2025.
- Charles Schwab opened 158 new positions and closed 137 in Q2 2025.
- Charles Schwab's portfolio value rose 8.5% quarter-over-quarter to $578B.
Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.